Biomedical Engineering Reference
In-Depth Information
29. Javanaud, C.: The application of a fractal model to the scattering of ultrasound in biological
media. J. Acoust. Soc. Am. 86 , 493-496 (1989)
30. Kearns, C.M., Gianni, L., Egorin, M.J.: Paclitaxel pharmacokinetics and pharmacodynamics.
Semin. Oncol. 22 , 16-23 (1995)
31. Kirkpatrick, S., Gelatt, C.D. Jr, Vecchi, M.P.: Optimization by simulated annealing. Science
220 , 671-680 (1983)
32. Klymko, P.W., Kopelman, R.: Heterogeneous exciton kinetics: Triplet naphthalene homofusion
in an isotopic mixed crystal. J. Phys. Chem. 86 , 3686-3688 (1982)
33. Kopelman, R.: Rate processes on fractals: Theory, simulations, and experiments. J. Stat. Phys.
42 , 185-200 (1986)
34. Kopelman, R.: Fractal reaction kinetics. Science 241 , 1620-1626 (1988)
35. Kosmidis, K., Karalis, V., Argyrakis, P., Macheras, P.: Michaelis-Menten kinetics under
spatially constrained conditions: Application to mibefradil pharmacokinetics. Biophys. J. 87 ,
1498-1506 (2004)
36. Kuh, H.J., Jang, S.H., Wientjes, M.G., Au, J.L.: Computational model of intracellular
pharmacokinetics of paclitaxel. J. Pharmacol. Exp. Ther. 293 , 761-770 (2000)
37. Landaw, E.M., Katz, D.: Comments on mean residence time determination. J. Pharmacokinet.
Biopharm. 13 , 543-547 (1985)
38. Levy, R.H.: Time-dependent pharmacokinetics. Pharmacol. Ther. 17 , 383-397 (1982)
39. Levy, R.H., Bauer, L.A.: Basic pharmacokinetics. Ther. Drug Monit. 8 , 47-58 (1986)
40. Lin, J.H.: Dose-dependent pharmacokinetics: Experimental observations and theoretical con-
siderations. Biopharm. Drug Dispos. 15 , 1-31 (1994)
41. L opez-Quintela, M.A., Casado, J.: Revision of the methodology in enzyme kinetics: A fractal
approach. J. Theor. Biol. 139 , 129-139 (1989)
42. Macheras, P.: A fractal approach to heterogeneous drug distribution: Calcium pharmacokinet-
ics. Pharm. Res. 13 , 663-670 (1996)
43. Mandelbrot, B.B.: Fractals: Form, Chance, and Dimension. W.H. Freeman, San Francisco
(1977)
44. Mandelbrot, B.B.: The Fractal Geometry of Nature. W.H. Freeman, San Francisco (1982)
45. Marsh, R.E., Tuszynski, J.A.: Fractal Michaelis-Menten kinetics under steady state conditions,
application to mibefradil. Pharmaceut. Res. 23 , 2760-2767 (2006)
46. Marsh, R.E., Tuszynski, J.A., Sawyer, M.B., Vos, K.J.E.: Emergence of power laws in the
pharmacokinetics of paclitaxel due to competing saturable processes. J. Pharm. Pharm. Sci.
11 , 77-96 (2008)
47. Marsh, R.E., Tuszynski, J.A., Sawyer, M., Vos, K.J.E.: A model of competing saturable kinetic
processes with application to the pharmacokinetics of the anticancer drug paclitaxel. Math.
Biosci. Eng. 8 , 325-354 (2011)
48. Marshall, J.H.: Calcium pools and the power function. In: Bergner, P.E., Lushbaugh, C.C.
(eds.) Compartments, Pools, and Spaces in Medical Physiology. USAEC Division of Technical
Information, Oak Ridge TN (1967)
49. McLeod, H.L., Kearns, C.M., Kuhn, J.G., Bruno, R.: Evaluation of the linearity of docetaxel
pharmacokinetics. Canc. Chemother. Pharmacol. 42 , 155-159 (1998)
50. Newhouse, J.S., Kopelman, R.: Reaction kinetics on clusters and islands. J. Chem. Phys. 85 ,
6804-6806 (1986)
51. Norris, W.P., Tyler, S.A., Brues, A.M.: Retention of radioactive bone-seekers. Science 128 ,
456-462 (1958)
52. Norwich, K.H., Siu, S.: Power functions in physiology and pharmacology. J. Theor. Biol. 95 ,
387-398 (1982)
53. Ogihara, T., Tamai, I., Tsuji, A.: Application of fractal kinetics for carrier-mediated transport
of drugs across intestinal epithelial membrane. Pharm. Res. 15 , 620-625 (1998)
54. Pazdur, R., Kudelka, A.P., Kavanagh, J.J., Cohen, P.R., Raber, M.N.: The taxoids: Paclitaxel
(Taxol) and docetaxel (Taxotere). Canc. Treat. Rev. 19 , 351-386 (1993)
Search WWH ::




Custom Search